|
EP1156781B1
(en)
|
1999-02-26 |
2005-06-08 |
Chiron Corporation |
Microemulsions with adsorbed macromolecules and microparticles
|
|
AU7398200A
(en)
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
|
CA2434546C
(en)
|
2001-01-12 |
2012-09-11 |
Chiron Corporation |
Induction of immune response by a replication-defective venezuelan equine encephalitis-sindbis chimeric virus replicon particle encoding an antigen
|
|
ES2330202T5
(es)
|
2001-09-06 |
2014-01-20 |
Alphavax, Inc. |
Sistemas vectores basados en replicones de alfavirus
|
|
US7416840B2
(en)
|
2002-12-13 |
2008-08-26 |
Fox Chase Cancer Center |
Replication of hepatitis C virus in non-hepatic epithelial and mouse hepatic cells
|
|
US20090252721A1
(en)
*
|
2003-09-18 |
2009-10-08 |
Thomas Buschmann |
Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
|
|
WO2005107760A1
(en)
|
2004-04-30 |
2005-11-17 |
Irm Llc |
Compounds and compositions as inducers of keratinocyte differentiation
|
|
CN1989250B
(zh)
|
2004-05-18 |
2013-11-20 |
阿尔法瓦克斯公司 |
Tc-83衍生的甲病毒属载体、颗粒和方法
|
|
TWI388344B
(zh)
|
2005-08-23 |
2013-03-11 |
Celsion Corp |
儲存奈米微粒調合物之方法
|
|
KR101499750B1
(ko)
|
2006-02-27 |
2015-03-06 |
더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 |
가감염성 플라비바이러스 및 이들의 용도
|
|
PL2068918T5
(pl)
|
2006-09-26 |
2024-12-02 |
Access To Advanced Health Institute |
Kompozycja szczepionki zawierająca syntetyczny adiuwant
|
|
BRPI0809926B8
(pt)
|
2007-04-04 |
2021-05-25 |
Infectious Disease Res Inst |
composição que compreende antígenos de mycobacterium tuberculosis, polipeptídeo de fusão isolado, polinucleotídeo isolado que codifica o dito polipeptídeo e uso da dita composição para estimular uma resposta imune protetora
|
|
CN101868180A
(zh)
|
2007-10-09 |
2010-10-20 |
圣路易斯华盛顿州立大学 |
成像粒子
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
US9333163B2
(en)
|
2008-10-06 |
2016-05-10 |
Massachusetts Institute Of Technology |
Particles with multiple functionalized surface domains
|
|
KR20110126717A
(ko)
|
2009-02-24 |
2011-11-23 |
더 스크립스 리서치 인스티튜트 |
단백질 생성 증강을 위한 ｍｒｎａ １차 구조의 재구조화
|
|
CA2764374C
(en)
|
2009-06-05 |
2019-11-19 |
Infectious Disease Research Institute |
Synthetic glucopyranosyl lipid adjuvants
|
|
DK2509634T3
(en)
|
2009-12-11 |
2019-04-23 |
Pfizer |
Stable formulations for lyophilization of therapeutic particles
|
|
KR101915699B1
(ko)
|
2010-06-10 |
2018-11-06 |
유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 |
데스모글레인 2(디에스쥐2)와 아데노바이러스의 상호작용을 위한 방법 및 시스템
|
|
US9555136B2
(en)
|
2010-06-21 |
2017-01-31 |
University Of Washington Through Its Center For Commercialization |
Coated magnetic nanoparticles
|
|
ES2646669T3
(es)
*
|
2010-07-06 |
2017-12-14 |
Glaxosmithkline Biologicals Sa |
Procedimientos de aumento de una respuesta inmunitaria mediante el suministro de ARN
|
|
ES2557382T3
(es)
*
|
2010-07-06 |
2016-01-25 |
Glaxosmithkline Biologicals Sa |
Liposomas con lípidos que tienen un valor de pKa ventajoso para el suministro de ARN
|
|
NZ606591A
(en)
|
2010-07-06 |
2015-02-27 |
Novartis Ag |
Cationic oil-in-water emulsions
|
|
JP6059220B2
(ja)
|
2011-07-06 |
2017-01-18 |
ノバルティス アーゲー |
核酸を含む水中油型エマルジョン
|
|
US9101669B2
(en)
|
2012-01-31 |
2015-08-11 |
Postech Academy-Industry Foundation |
Self-assembed conjugate and use thereof
|
|
HUE065746T2
(hu)
|
2012-08-03 |
2024-06-28 |
Access To Advanced Health Inst |
Készítmények és eljárások aktív mycobacterium tuberculosis fertõzés kezelésére
|
|
WO2014130761A2
(en)
|
2013-02-22 |
2014-08-28 |
President And Fellows Of Harvard College |
Nanostructured active therapeutic vehicles and uses thereof
|
|
US9775894B2
(en)
|
2013-07-09 |
2017-10-03 |
University Of Washington Through Its Center For Commercialization |
Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling
|
|
RU2546249C2
(ru)
|
2013-08-07 |
2015-04-10 |
Силезиа Груп Пте. Лтд. |
Композиция для усиления экспрессии трансгена в эукариотических клетках и способ увеличения продукции целевого белка, кодируемого трансгеном
|
|
IL310015B2
(en)
|
2013-12-31 |
2026-02-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
PL4023249T3
(pl)
|
2014-04-23 |
2025-03-10 |
Modernatx, Inc. |
Szczepionki z kwasem nukleinowym
|
|
TWI696700B
(zh)
|
2015-01-16 |
2020-06-21 |
國立研究開發法人產業技術總合研究所 |
使用具有匿跡性之ｒｎａ的基因表現系統及含有該ｒｎａ的基因導入、表現載體
|
|
CN108064176A
(zh)
*
|
2015-04-22 |
2018-05-22 |
库瑞瓦格股份公司 |
用于治疗肿瘤疾病的含有rna的组合物
|
|
CN106176599A
(zh)
|
2015-05-06 |
2016-12-07 |
江苏天士力帝益药业有限公司 |
一种卡巴他赛脂肪乳注射剂及其制备方法
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
AU2016338672A1
(en)
|
2015-10-16 |
2018-04-12 |
Marinus Pharmaceuticals, Inc. |
Injectable neurosteroid formulations containing nanoparticles
|
|
WO2017070624A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Tropical disease vaccines
|
|
JP7384512B2
(ja)
*
|
2015-10-22 |
2023-11-21 |
モデルナティエックス インコーポレイテッド |
広域インフルエンザウイルスワクチン
|
|
AU2016341309A1
(en)
*
|
2015-10-22 |
2018-06-07 |
Modernatx, Inc. |
Cancer vaccines
|
|
US10801041B2
(en)
*
|
2015-11-18 |
2020-10-13 |
Orbis Health Solutions, Llc |
T7 alpha viral vector system
|
|
PL3386484T3
(pl)
*
|
2015-12-10 |
2022-07-25 |
Modernatx, Inc. |
Kompozycje i sposoby dostarczania środków terapeutycznych
|
|
JP7250520B2
(ja)
|
2016-04-13 |
2023-04-03 |
ヤンセン ファーマシューティカルズ，インコーポレーテッド |
組換えアルテリウイルスレプリコン系およびその使用
|
|
DE102017206254B4
(de)
|
2016-04-13 |
2024-07-11 |
Dialog Semiconductor (Uk) Limited |
DC-DC-Umwandlung für Mehrzellen-Batterien
|
|
MX2018014086A
(es)
|
2016-05-16 |
2019-09-18 |
Infectious Disease Res Inst |
Formulacion que contiene agonista tlr y metodos de uso.
|
|
WO2017200957A1
(en)
|
2016-05-16 |
2017-11-23 |
Infectious Disease Research Institute |
Pegylated liposomes and methods of use
|
|
JP2019521095A
(ja)
|
2016-05-21 |
2019-07-25 |
インフェクシャス ディズィーズ リサーチ インスティチュート |
二次性結核および非結核性マイコバクテリウム感染症を治療するための組成物および方法
|
|
KR20250008135A
(ko)
|
2016-06-01 |
2025-01-14 |
액세스 투 어드밴스드 헬스 인스티튜트 |
사이징제를 함유하는 나노명반 입자
|
|
WO2017218704A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
WO2018022957A1
(en)
|
2016-07-29 |
2018-02-01 |
Tarveda Therapeutics, Inc. |
T cell binding conjugates and methods of use
|
|
KR20180025701A
(ko)
|
2016-09-01 |
2018-03-09 |
(주)아모레퍼시픽 |
특정 siRNA을 포함하는 멜라닌 증진용 조성물
|
|
BR112019004913B1
(pt)
|
2016-09-16 |
2022-07-12 |
Infectious Disease Research Institute |
Vacinas que compreendem polipeptídeos de mycobacterium leprae para a prevenção, tratamento e diagnóstico de lepra
|
|
KR102718353B1
(ko)
|
2016-10-17 |
2024-10-15 |
얀센 파마슈티칼즈, 인코포레이티드 |
재조합 바이러스 레플리콘 시스템 및 그의 용도
|
|
US20190274968A1
(en)
*
|
2016-10-27 |
2019-09-12 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an adaptive immune response
|
|
WO2018147710A1
(ko)
|
2017-02-13 |
2018-08-16 |
단디바이오사이언스 주식회사 |
이미다조퀴놀린계열 물질을 포함하는 나노에멀젼 및 이의 용도
|
|
CN107281161B
(zh)
|
2017-05-16 |
2020-02-21 |
浙江大学 |
一种药物纳米制剂及其制备方法
|
|
MX2019015076A
(es)
*
|
2017-06-15 |
2020-08-03 |
Infectious Disease Res Inst |
Portadores lípidos nanoestructurados y emulsiones estables y usos de los mismos.
|
|
WO2019126524A1
(en)
|
2017-12-20 |
2019-06-27 |
The Trustees Of Columbia University Of The City Of New York |
Therapeutic targets for nash-induced hepatocellular carcinoma
|
|
US12065649B2
(en)
|
2018-01-09 |
2024-08-20 |
Vanderbilt University |
Pattern recognition receptor agonist prodrugs and methods of use thereof
|
|
JP7494117B2
(ja)
|
2018-01-19 |
2024-06-03 |
ヤンセン ファーマシューティカルズ，インコーポレーテッド |
組換えレプリコン系を使用する免疫応答の誘導および増強
|
|
WO2019152884A1
(en)
|
2018-02-02 |
2019-08-08 |
University Of Washington |
Compositions and methods for inducing tripartite motif-containing protein 16 (trim16) signaling
|
|
US20190382450A1
(en)
|
2018-06-18 |
2019-12-19 |
University Of Maryland, College Park |
Newcastle disease virus-based vectored vaccine
|
|
US12390812B2
(en)
|
2018-12-19 |
2025-08-19 |
Nuclein, Llc |
Apparatus and methods for molecular diagnostics
|
|
WO2020146690A1
(en)
|
2019-01-10 |
2020-07-16 |
Massachusetts Institute Of Technology |
Methods for in vitro evolution of rna replicons
|
|
US11406699B2
(en)
|
2019-03-22 |
2022-08-09 |
George Mason University |
Alphavirus and compositions, methods, and kits related thereto
|
|
CA3141577A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
GB201908729D0
(en)
|
2019-06-18 |
2019-07-31 |
Imp College Innovations Ltd |
RNA construct
|
|
US12410241B2
(en)
|
2019-07-26 |
2025-09-09 |
Vanderbilt University |
Human monoclonal antibodies to enterovirus D68
|
|
WO2021067480A1
(en)
|
2019-10-02 |
2021-04-08 |
University Of Washington |
Compositions and methods for treatment of hepatitis b virus infection
|
|
WO2021072112A1
(en)
|
2019-10-09 |
2021-04-15 |
Hdt Bio Corp. |
Detection of desmoglein-2 in cancers of epithelial origin
|
|
WO2021076630A1
(en)
|
2019-10-14 |
2021-04-22 |
The Regents Of The University Of California |
Nano-enabled immunotherapy in cancer
|
|
IL295548A
(en)
|
2020-02-14 |
2022-10-01 |
Altimmune Inc |
Immunogenic compositions of the corona virus and their uses
|
|
WO2021178416A1
(en)
|
2020-03-02 |
2021-09-10 |
Heat Biologics, Inc. |
Immune-mediated coronavirus treatments
|
|
WO2021178886A1
(en)
|
2020-03-06 |
2021-09-10 |
Thomas Jefferson University |
Coronavirus disease (covid-19) vaccine
|
|
AU2021236068A1
(en)
|
2020-03-09 |
2022-10-06 |
Arcturus Therapeutics, Inc. |
Compositions and methods for inducing immune responses
|
|
KR20220156933A
(ko)
|
2020-03-23 |
2022-11-28 |
에이치디티 바이오 코포레이션 |
Rna의 전달을 위한 조성물 및 방법
|
|
TWI891771B
(zh)
|
2020-04-17 |
2025-08-01 |
美商Ｖｌｐ醫療股份有限公司 |
冠狀病毒疫苗
|
|
WO2022051022A1
(en)
|
2020-09-04 |
2022-03-10 |
Infectious Disease Research Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
|
EP4048308A1
(en)
|
2020-12-23 |
2022-08-31 |
Infectious Disease Research Institute |
Solanesol vaccine adjuvants and methods of preparing same
|
|
IN202121031414A
(https=)
|
2021-07-13 |
2023-01-13 |
|
|
|
IN202121038492A
(https=)
|
2021-08-25 |
2023-03-03 |
|
|
|
JP2024535354A
(ja)
*
|
2021-09-22 |
2024-09-30 |
エイチディーティー バイオ コーポレーション |
がん治療組成物およびその使用
|
|
WO2023056202A2
(en)
|
2021-09-22 |
2023-04-06 |
Hdt Bio Corp. |
Compositions and methods for enhanced protein production
|